YDES
YD BIO (YDES)
NASDAQ
$2.43-$0.15 (-5.78%)
Price as of Jun 23, 2026 7:57 PM EDT
  • N/A
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
Income Statement
Total Operating Revenue
596,817
N/A
Cost of Revenue
429,407
N/A
Gross Profit
167,410
N/A
Sales and Marketing Expense
170,523
N/A
Research and Development Expense
-1.6M
N/A
Depreciation and Amortization Expense
16,246
N/A
Total Operating Expenses
5.4M
N/A
Operating Profit
-5.3M
N/A
Interest Income
80,162
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
80,162
N/A
Total Nonoperating Income and Expense
-3.0M
N/A
Income before Taxes
-8.3M
N/A
Income Taxes
-1,531
N/A
Extraordinary Items
N/A
N/A
Net Income
-8.3M
N/A
Net Income from Continuing Operations Applicable to Common
-8.3M
N/A
Basic EPS and Net Income
-0.12
N/A
Diluted EPS and Net Income
-0.12
N/A
Basic Weighted Average Shares
66.7M
N/A
Diluted Weighted Average Shares
66.7M
N/A
Balance Sheet
Cash and Cash Equivalents
6.0M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.0M
N/A
Total Current Assets
9.7M
N/A
Accumulated Depreciation
28,576
N/A
Property and Plant and Equipment and Net
59,340
N/A
Total Long-Term Assets
59,340
N/A
Total Assets
13.8M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
1.6M
N/A
Total Long-Term Debt
6,764
N/A
Total Long-Term Liabilities
15.0M
N/A
Total Liabilities
16.6M
N/A
Retained Earnings
-10.2M
N/A
Total Stockholders Equity
-2.9M
N/A
Total Shares Outstanding
70.8M
N/A
Cash Flow
Cash from Operating Activities
-6.6M
N/A
Capital Expenditures
1.4M
N/A
Cash from Investing Activities
-1.4M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
10.9M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow